跳至主要内容
临床试验/NCT02295202
NCT02295202已完成4 期

Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome: A Randomized Study

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Reversibility of Metabolic Syndrome criteria

研究概览

简要总结

Obstructive Sleep Apnea (OSA) is a common condition that may induce hemodynamic and metabolic dysregulation. However, it is not clear if OSA is a mere epiphenomenon or contributes to increase the morbidity associated with metabolic syndrome. This study was designed to evaluate the impact of OSA treatment with CPAP in consecutive patients with metabolic syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Metabolic Syndrome (ATP III)
  • Moderate to severe OSA

排除标准

  • Patients under chronic use of medications
  • Neurological diseases
  • Coronary artery disease
  • Acute heart failure
  • Chronic renal failure (GFR < 30 ml/min)
  • Chronic obstructive pulmonary disease
  • Mild OSA and patients with BMI over 40 kg/m2.

结局指标

主要结局

Reversibility of Metabolic Syndrome criteria

时间窗: 6 months

次要结局

  • Hepatic steatosis(6 months)
  • coronary atherosclerosis(6 months)
  • Abdominal fat(6 months)
  • Inflammatory markers(6 months)
  • MicroRNAs(6 months)
  • endothelial function(6 months)
  • Metabolomics(6 months)
  • Heart remodeling(6 months)
  • carotid intima-media thickness(6 months)
  • Epicardic fat(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Luciano F Drager, MD, PhD

Luciano F. Drager

University of Sao Paulo

研究点 (1)

Loading locations...

相似试验